Bases Neurobiológicas y Psicológicas de los Trastornos Mentales. Trastornos del Neurodesarrollo

Leza, JC; Garcia-Bueno, B; Bioque, M; Arango, C; Parellada, M; Do, K; O'Donnell, P; Bernardo, M.

Inflammation in schizophrenia: A question of balance

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2015; 55: 612-626 Nº de citas: 166 [doi:10.1016/j.neubiorev.2015.05.014]

Carmona, S; Hoekzema, E; Castellanos, FX; Garcia-Garcia, D; Lage-Castellanos, A; Van Dijk, KRA; Navas-Sanchez, FJ; Martinez, K; Desco, M; Sepulcre, J.

Sensation-to-cognition cortical streams in attention-deficit/hyperactivity disorder

HUMAN BRAIN MAPPING. 2015; 36(7): 2544-2557 Nº de citas: 44 [doi:10.1002/hbm.22790]

Sanchez-Gistau, V; Baeza, I; Arango, C; Gonzalez-Pinto, A; de la Serna, E; Parellada, M; Graell, M; Paya, B; Llorente, C; Castro-Fornieles, J.

The affective dimension of early-onset psychosis and its relationship with suicide

JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY. 2015; 56(7): 747-755 Nº de citas: 35 [doi:10.1111/jcpp.12332]

SANTIAGO GARCÍA, BEGOÑA; GUERRA SÁNCHEZ, LUIS; Garcia-Morin, M; Gonzalez, E; Gonzalvez, A; Izquierdo, G; Martos, A; SANTOS SEBASTIAN, MAR; NAVARRO GÓMEZ, MARÍA LUISA; HERNÁNDEZ-SAMPELAYO MATOS, TERESA; SAAVEDRA LOZANO, JESÚS.

Clostridium difficile isolation in children hospitalized with diarrhea

ANALES DE PEDIATRIA. 2015; 82(6): 417-425 Nº de citas: 8 [doi:10.1016/j.anpedi.2014.07.015]

Rapado-Castro, M; McGorry, PD; Yung, A; Calvo, A; Nelson, B.

Sources of clinical distress in young people at ultra high risk of psychosis

Schizophrenia Research. 2015; 165(1): 15-21 Nº de citas: 51 [doi:10.1016/j.schres.2015.03.022]

Leucht, S; Winter-van Rossum, I; Heres, S; Arango, C; Fleischhacker, WW; Glenthoj, B; Leboyer, M; Leweke, FM; Lewis, S; McGuire, P; Meyer-Lindenberg, A; Rujescu, D; Kapur, S; Kahn, RS; Sommer, IE.

The Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) Trial: Rationale for Its Methodology and a Review of the Effectiveness of Switching Antipsychotics

SCHIZOPHRENIA BULLETIN. 2015; 41(3): 549-558 Nº de citas: 52 [doi:10.1093/schbul/sbv019]

Fond, G; d'Albis, MA; Jamain, S; Tamouza, R; Arango, C; Fleischhacker, WW; Glenthoj, B; Leweke, M; Lewis, S; McGuire, P; Meyer-Lindenberg, A; Sommer, IE; Winter-van Rossum, I; Kapur, S; Kahn, RS; Rujescu, D; Leboyer, M.

The Promise of Biological Markers for Treatment Response in First-Episode Psychosis: A Systematic Review

SCHIZOPHRENIA BULLETIN. 2015; 41(3): 559-573 Nº de citas: 79 [doi:10.1093/schbul/sbv002]

Dazzan, P; Arango, C; Fleischacker, W; Galderisi, S; Glenthoj, B; Leucht, S; Meyer-Lindenberg, A; Kahn, R; Rujescu, D; Sommer, I; Winter, I; McGuire, P.

Magnetic Resonance Imaging and the Prediction of Outcome in First-Episode Schizophrenia: A Review of Current Evidence and Directions for Future Research

SCHIZOPHRENIA BULLETIN. 2015; 41(3): 574-583 Nº de citas: 83 [doi:10.1093/schbul/sbv024]

Drake, RJ; Nordentoft, M; Haddock, G; Arango, C; Fleischhacker, WW; Glenthoj, B; Leboyer, M; Leucht, S; Leweke, M; McGuire, P; Meyer-Lindenberg, A; Rujescu, D; Sommer, IE; Kahn, RS; Lewis, SW.

Modeling Determinants of Medication Attitudes and Poor Adherence in Early Nonaffective Psychosis: Implications for Intervention

SCHIZOPHRENIA BULLETIN. 2015; 41(3): 584-596 Nº de citas: 37 [doi:10.1093/schbul/sbv015]

Arango, C.

Present and future of developmental neuropsychopharmacology

EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2015; 25(5): 703-712 Nº de citas: 15 [doi:10.1016/j.euroneuro.2014.11.003]

Cuesta, MJ; Sanchez-Torres, AM; Cabrera, B; Bioque, M; Merchan-Naranjo, J; Corripio, I; Gonzalez-Pinto, A; Lobo, A; Bombin, I; de la Serna, E; Sanjuan, J; Parellada, M; Saiz-Ruiz, J; Bernardo, M.

Premorbid adjustment and clinical correlates of cognitive impairment in first-episode psychosis. The PEPsCog Study

Schizophrenia Research. 2015; 164(1-3): 65-73 Nº de citas: 95 [doi:10.1016/j.schres.2015.02.022]

Rapado-Castro, M; Pazos, A; Fananas, L; Bernardo, M; Ayuso-Mateos, JL; Leza, JC; Berrocoso, E; de Arriba, J; Roldan, L; Sanjuan, J; Perez, V; Haro, JM; Palomo, T; Valdizan, EM; Mico, JA; Sanchez, M; Arango, C.

Building up careers in translational neuroscience and mental health research: Education and training in the Centre for Biomedical Research in Mental Health

Spanish Journal of Psychiatry and Mental Health. 2015; 8(2): 65-74 Nº de citas: 8 [doi:10.1016/j.rpsm.2014.09.003]

Thomson, D; Berk, M; Dodd, S; Rapado-Castro, M; Quirk, SE; Ellegaard, PK; Berk, L; Dean, OM.

Tobacco Use in Bipolar Disorder

Clinical Psychopharmacology and Neuroscience. 2015; 13(1): 1-11 Nº de citas: 49 [doi:10.9758/cpn.2015.13.1.1]

Pina-Camacho, L; Garcia-Prieto, J; Parellada, M; Castro-Fornieles, J; Gonzalez-Pinto, AM; Bombin, I; Graell, M; Paya, B; Rapado-Castro, M; Janssen, J; Baeza, I; Del Pozo, F; Desco, M; Arango, C.

Predictors of schizophrenia spectrum disorders in early-onset first episodes of psychosis: a support vector machine model

EUROPEAN CHILD & ADOLESCENT PSYCHIATRY. 2015; 24(4): 427-440 Nº de citas: 37 [doi:10.1007/s00787-014-0593-0]

Díaz-Caneja CM; Pina-Camacho L; Rodríguez-Quiroga A; Fraguas D; Parellada M; Arango C.

Predictors of outcome in early-onset psychosis: a systematic review.

NPJ Schizophrenia. 2015; 1: 14005-14005 Nº de citas: 174 [doi:10.1038/npjschz.2014.5]

Rapado-Castro, M; Berk, M; Venugopal, K; Bush, AI; Dodd, S; Dean, OM.

Towards stage specific treatments: Effects of duration of illness on therapeutic response to adjunctive treatment with N-acetyl cysteine in schizophrenia

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2015; 57: 69-75 Nº de citas: 37 [doi:10.1016/j.pnpbp.2014.10.002]

Allott, KA; Rapado-Castro, M; Proffitt, TM; Bendall, S; Garner, B; Butselaar, F; Markulev, C; Phassouliotis, C; McGorry, PD; Wood, SJ; Cotton, SM; Phillips, LJ.

The impact of neuropsychological functioning and coping style on perceived stress in individuals with first-episode psychosis and healthy controls

PSYCHIATRY RESEARCH. 2015; 226(1): 128-135 Nº de citas: 34 [doi:10.1016/j.psychres.2014.12.032]

Sole, B; Bonnin, C; Mayoral, M; Amann, BL; Torres, I; Gonzalez-Pinto, A; Jimenez, E; Crespo, J; Colom, F; Tabares-Seisdedos, R; Reinares, M; Ayuso-Mateos, JL; Soria, S; Garcia-Portilla, MP; Ibnanez, A; Vieta, E; Martinez-Aran, A; Torrent, C.

Functional remediation for patients with bipolar II disorder: Improvement of functioning and subsyndromal symptoms

EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2015; 25(2): 257-264 Nº de citas: 45 [doi:10.1016/j.euroneuro.2014.05.010]